Pathogen Distribution, Drug Resistance Risk Factors, and Construction of Risk Prediction Model for Drug-Resistant Bacterial Infection in Hospitalized Patients at the Respiratory Department During the COVID-19 Pandemic

Xiao-Lin Wei,Qiang-Lin Zeng,Min Xie,Yong Bao
DOI: https://doi.org/10.2147/IDR.S399622
2023-02-23
Infection and Drug Resistance
Abstract:Xiao-Lin Wei, 1 Qiang-Lin Zeng, 2 Min Xie, 3 Yong Bao 1 1 Department of Respirology, Taikang Sichuan Hospital, Chengdu, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Chengdu University School of Clinical Medicine, Chengdu University, Chengdu, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China Correspondence: Yong Bao, Department of Respirology, Taikang Sichuan Hospital, No. 881, Xianghe 1st Street, Huayang Street, Tianfu New District, Sichuan, 610213, People's Republic of China, Email Objective: To investigate the distribution and drug resistance of pathogens among hospitalized patients in the respiratory unit during the COVID-19 pandemic, analyze the risk factors of drug resistance, construct a risk prediction model. Methods: This study isolated 791 strains from 489 patients admitted to the Affiliated Hospital of Chengdu University, who were retrospectively enrolled between December 2019 and June 2021. The patients were divided into training and validation sets based on a random number table method (8:2). The baseline information, clinical characteristics, and culture results were collected using an electronic database and WHONET 5.6 software and compared between the two groups. A risk prediction model for drug-resistant bacteria was constructed using multi-factor logistic regression. Results: K. pneumoniae (24.78%), P. aeruginosa (17.19%), A. baumannii (10.37%), and E. coli (10.37%) were the most abundant bacterial isolates. 174 isolates of drug-resistant bacteria were collected, ie, Carbapenem-resistant organism-strains, ESBL-producing strains, methicillin-resistant S. aureus , multi-drug resistance constituting 38.51%, 50.57%, 6.32%, 4.60%, respectively. The nosocomial infection prediction model of drug-resistant bacteria was developed based on the combined use of antimicrobials, pharmacological immunosuppression, PCT> 0.5 ng/mL, CKD stage 4– 5, indwelling catheter, and age > 60 years. The AUC under the ROC curve of the training and validation sets were 0.768 (95% CI: 0.624– 0.817) and 0.753 (95% CI: 0.657– 0.785), respectively. Our model revealed an acceptable prediction demonstrated by a non-significant Hosmer-Lemeshow test (training set, p=0.54; validation set, p=0.88). Conclusion: K. pneumoniae, P. aeruginosa, A. baumannii , and E. coli were the most abundant bacterial isolates. Antimicrobial resistance among the common isolates was high for most routinely used antimicrobials and carbapenems. COVID-19 did not increase the drug resistance pressure of the main strains. The risk prediction model of drug-resistant bacterial infection is expected to improve the prevention and control of antibacterial-resistant bacterial infection in hospital settings. Keywords: COVID-19, respiratory and critical care medicine, drug-resistant bacteria, risk factors, line chart Antimicrobial resistance (AMR) has become more prevalent in recent years due to the widespread use of antibiotics in clinical practice. Drug-resistant bacterial infection significantly increases the mortality rate, hospitalization time, and treatment cost, which increases with age. 1 By 2050, the number of bacterial infections is expected to rise to 10 million, indicating that bacterial resistance is a serious threat to global health. 2 Among these, nosocomial infections caused by Gram-negative bacilli (GNB) are the most challenging issue for dealing with AMR. 3 Lower respiratory tract infections (LRTIs) are common infections across the globe and a major cause of illness and death targeting people of all ages. 4 Antimicrobials are commonly used to treat LRTIs and drug-resistant bacteria are commonly detected in respiratory departments. In line with the standard construction of the national respiratory and critical medicine department in China, large tertiary hospitals are equipped with respiratory and critical medicine departments and independent respiratory intensive care unit (RICU) wards. Patients in RICU usually have severe infections that necessitate the use of high-grade antimicrobials; as a result, the diagnostic and treatment environment for patients has improved due to increased detection of drug-resistant bacteria. 5 The Coronavirus Disease 2019 (COVID-19) infection has affected people globally, and the number of cases continues to increase. Studies indicate that the probability of bacterial and fungal infections occurring in patients with COVID-19 infection is extremely low. 6–8 Patients h -Abstract Truncated-
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?